Sahrun, S. and Wulandari, L. (2019) “Case report: Management of Progressive Lung Cancer Patients after First-Line EGFR Tyrosine Kinase Inhibitor Therapy”, Folia Medica Indonesiana, 55(3), pp. 239–245. doi: 10.20473/fmi.v55i3.15509.